Intoxications due to ingestion of γ-butyrolactone: Organ distribution of γ-hydroxybutyric acid and γ-butyrolactone

Therapeutic Drug Monitoring

Volumn 30, Issue 6, 2008, Pages 755-761

  Lenz, Daniel ^a   Rothschild, Markus A ^a   Kröner, Lars ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

butyrolactone; hydroxybutyrate; Fatality; Intoxication; Organ distribution

Indexed keywords

4 HYDROXYBUTYRIC ACID; GAMMA BUTYROLACTONE;

ACCIDENTAL DEATH; ADULT; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; COMATOSE PATIENT; DRUG INTOXICATION; EMERGENCY WARD; FEMALE; HUMAN; HUMAN TISSUE; INGESTION; MALE; MASS FRAGMENTOGRAPHY; ORGAN DISTRIBUTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUICIDE; VALIDATION STUDY;

4-BUTYROLACTONE; ADULT; BRAIN; FEMALE; HUMANS; HYDROXYBUTYRATES; MALE; MUSCLE, SKELETAL; SUBSTANCE-RELATED DISORDERS; TISSUE DISTRIBUTION;

EID: 57749102002     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181898c2e     Document Type: Article

References (36)

1. Couper FJ, Marinetti LJ. γ-Hydroxybutyrate (GHB) - effects on human performance and behavior. Forensic Sci Rev. 2002;14:102-121. Available at: http://www.ndaa.org/pdf/ntlc_ghb.pdf [National District Attorneys Association Web site]. Accessed March 29, 2007.
2. VanCauter E, Plat L, Scharf MB, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest. 1997;100:745-753.
3. Takahara J, Yunoki S, Yakushiji W, et al. Stimulatory effects of gamma-hydroxybutyric acid on growth-hormone and prolactin-release in humans. J Clin Endocrinol Metab. 1977;44:1014-1017.
4. Couper FJ, Thatcher JE, Logan BK. Suspected GHB overdoses in the emergency department. J Anal Toxicol. 2004;28:481-484.
5. Okun MS, Boothby LA, Bartfield RB, et al. GHB: an important pharmacologic and clinical update. J Pharm Pharm Sci. 2001;4:167-175.
6. Ferrara SD, Zotti S, Tedeschi L, et al. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol. 1992;34:231-235.
7. Brenneisen R, ElSohly MA, Murphy TP, et al. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol. 2004;28:625-630.
8. Ferrara SD, Tedeschi L, Frison G, et al. Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas-chromatography mass-spectrometry. J Pharm Biomed Anal. 1993;11:483-487.
9. EMEA. Xyrem - Scientific Discussion. EMEA Web site. Available at: http://www.emea.europa.eu/humandocs/PDFs/EPAR/xyrem/324056en6.pdf. Accessed March 7, 2007.
10. Elliott SP. Nonfatal instances of intoxication with gamma-hydroxybutyrate in the United Kingdom. Ther Drug Monit. 2004;26:432-440.
11. Van Sassenbroeck DK, De Neve N, De Paepe P, et al. Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series. Clin Toxicol. 2007;45:533-538.
12. Duer WC, Byers KL, Martin JV. Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol. J Anal Toxicol. 2001;25:576-582.
13. Marinetti LJ, Isenschmid DS, Hepler BR, et al. Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage. J Anal Toxicol. 2005;29:41-47.
14. Root B. Oral premedication of children with 4-hydroxbutyrate. Anesthesiology. 1965;26:259-260.
15. Guidotti A, Ballotti PL. Relationship between pharmacological effects and blood and brain levels of gamma-butyrolactone and gamma-hydroxybutyrate. Biochem Pharmacol. 1970;19:883-894.
16. Lettieri J, Fung HL. Improved pharmacological activity via pro-drug modification-comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Res Commun Mol Pathol Pharmacol. 1978;22:107-118.
17. Arena C, Fung HL. Absorption of sodium gamma-hydroxybutyrate and its prodrug gamma-butyrolactone - relationship between in vitro transport and in vivo absorption. J Pharm Sci. 1980;69:356-358.
18. Carter LP, Koek W, France CP. Lack of effects of GHB precursors GBL and 1,4-BD following i.c.v. administration in rats. Eur J Neurosci. 2006;24:2595-2600.
19. Kintz P, Villain M, Cirimele V, et al. GHB in postmortem toxicology discrimination between endogenous production from exposure using multiple specimens. Forensic Sci Int. 2004;143:177-181.
20. Elliott SP. Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of findings. J Anal Toxicol. 2004;28:20-26.
21. Berankova K, Mutnanska K, Balikova M. Gamma-hydroxybutyric acid stability and formation in blood and urine. Forensic Sci Int. 2006;161:158-162.
22. Musshoff F, Lachenmeier DW, Kroener L, et al. Automated headspace solid-phase dynamic extraction for the determination of amphetamines and synthetic designer drugs in hair samples. J Chromatogr A. 2002;958:231-238.
23. Bicchi C, Cordero C, Liberto E, et al. Automated headspace solid-phase dynamic extraction to analyse the volatile fraction of food matrices. J Chromatogr A. 2004;1024:217-226.
24. Jochmann MA, Yuan X, Schmidt TC. Determination of volatile organic hydrocarbons in water samples by solid-phase dynamic extraction. Anal Bioanal Chem. 2007;387:2163-2174.
25. Kalasinsky KS, Dixon MM, Schmunk GA, et al. Blood, brain, and hair GHB concentrations following fatal ingestion. J Forensic Sci. 2001;46:728-730.
26. Mazarr-Proo S, Kerrigan S. Distribution of GHB in tissues and fluids following a fatal overdose. J Anal Toxicol. 2005;29:398-400.
27. Ferrara SD, Tedeschi L, Frison G, et al. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication. J Forensic Sci. 1995;40:501-504.
28. Thai D, Dyer JE, Benowitz NL, et al. Gamma-hydroxybutyrate and ethanol effects and interactions in humans. J Clin Psychopharmacol. 2006;26:524-529.
29. Kintz P, Villain M, Pelissier AL, et al. Unusually high concentrations in a fatal GHB case. J Anal Toxicol. 2005;29:582-585.
30. Ciolino LA, Mesmer MZ, Satzger RD, et al. The chemical interconversion of GHB and GBL: forensic issues and implications. J Forensic Sci. 2001;46:1315-1323.
31. Roth RH, Giarman NJ. Gamma-butyrolactone and gamma-hydroxybutyric acid. I. Distribution and metabolism. Biochem Pharmacol. 1966;15:1333-1348.
32. Fishbein WN, Bessman SP. Purification and properties of an enzyme in human blood and rat liver microsomes catalyzing formation and hydrolysis of gamma-lactones. I. Tissue localization stoichiometry specificity distinction from esterase. J Biol Chem. 1966;241:4835-4841.
33. +-dependent oxidoreductase in the catabolism of gamma-hydroxybutyrate in vivo. J Neurochem. 1987;48:1935-1941.
34. Brown JJ, Nanayakkara CS. Acetone-free nail polish removers: are they safe? Clin Toxicol. 2005;43:297-299.
35. Rambourg-Schepens MO, Buffet M, Durak C, et al. Gamma butyrolactone poisoning and its similarities to gamma hydroxybutyric acid: two case reports. Vet Hum Toxicol. 1997;39:234-235.
36. Savage T, Khan A, Loftus BG. Acetone-free nail polish remover pads: toxicity in a 9-month old. Arch Dis Child. 2007;92:371.